Reclipsen Interactions
There are 455 drugs known to interact with Reclipsen (desogestrel/ethinyl estradiol), along with 22 disease interactions, and 7 alcohol/food interactions. Of the total drug interactions, 50 are major, 358 are moderate, and 47 are minor.
- View all 455 medications that may interact with Reclipsen
- View Reclipsen alcohol/food interactions (7)
- View Reclipsen disease interactions (22)
Most frequently checked interactions
View interaction reports for Reclipsen (desogestrel / ethinyl estradiol) and the medicines listed below.
- Abilify (aripiprazole)
- Adderall XR (amphetamine / dextroamphetamine)
- Benadryl (diphenhydramine)
- biotin
- bupropion
- citalopram
- clonazepam
- cyclobenzaprine
- Cymbalta (duloxetine)
- gabapentin
- ibuprofen
- lamotrigine
- levothyroxine
- Lexapro (escitalopram)
- lorazepam
- metformin
- naproxen
- omeprazole
- prednisone
- propranolol
- ranitidine
- sertraline
- spironolactone
- Topamax (topiramate)
- tramadol
- trazodone
- venlafaxine
- Vitamin D3 (cholecalciferol)
- Zoloft (sertraline)
- Zyrtec (cetirizine)
Reclipsen alcohol/food interactions
There are 7 alcohol/food interactions with Reclipsen (desogestrel / ethinyl estradiol).
Reclipsen disease interactions
There are 22 disease interactions with Reclipsen (desogestrel / ethinyl estradiol) which include:
- smoking
- abnormal vaginal bleeding
- carcinomas (estrogenic)
- hypercalcemia in breast cancer
- hypertension
- thromboembolism/cardiovascular
- hepatic neoplasms
- liver disease
- thromboembolism
- angioedema
- gallbladder disease
- hypercalcemia
- hyperlipidemia
- liver disease
- melasma
- depression
- fluid retention
- glucose intolerance
- retinal thrombosis
- thyroid function tests
- hyperlipidemia
- weight gain
More about Reclipsen (desogestrel / ethinyl estradiol)
- Reclipsen consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (151)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: contraceptives
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.